Worse Neurologic Outcomes Observed in Pediatric COVID-19-associated Encephalopathy Than in Influenza-associated Encephalopathy
The clinical characteristics of the 2 groups were similar; however, patients with COVID-19-associated encephalopathy showed worse discharge neurologic outcomes, warranting cautious interpretation. Enhancing public awareness of the severe outcomes and conducting further research is essential for better understanding its pathogenesis and treatment.
Authors
- Mihoko Furuichi
- Eisuke Suganuma (ORCID: https://orcid.org/0000-0002-6711-9474)
- Munehiro Furuichi (ORCID: https://orcid.org/0000-0001-7742-1135)
- Chikara Ogimi (ORCID: https://orcid.org/0000-0002-2166-8152)
- Kenjiro Kikuchi (ORCID: https://orcid.org/0000-0002-4844-6082)
- Mitsuo Motobayashi (ORCID: https://orcid.org/0000-0003-3412-6819)
- Yuto Otsubo (ORCID: https://orcid.org/0000-0001-8184-6873)
- Haruka Takei (ORCID: https://orcid.org/0000-0001-8265-2448)
- T Takeuchi (ORCID: https://orcid.org/0000-0002-6006-5258)
- Shota Yamamoto (ORCID: https://orcid.org/0000-0003-1320-390X)
- Ryohei Futatsugi
Institutions
- Keio University (JP)
- Saitama Children's Medical Center (JP)
- Japanese Red Cross Nagoya Daiichi Hospital (JP)
- National Center For Child Health and Development (JP)
- Chiba Hospital (JP)
- Nagano Children's Hospital (JP)
- Tokyo Metropolitan Children's Medical Center (JP)
Publication Details
- Journal
- The Pediatric Infectious Disease Journal
- Published
- 2025-11-07
- DOI
- https://doi.org/10.1097/inf.0000000000005040
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 0.00